Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: A review of claims submitted to the National Vaccine Injury Compensation Program

Pediatrics

Volumn 101, Issue 3 I, 1998, Pages 383-387

  Weibel, Robert E ^a   Caserta, Vito ^a   Benor, David E ^b   Evans, Geoffrey ^a  

^a HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^b Office of the Surgeon General   (United States)

Author keywords

Encephalitis; Encephalopathy; Measles vaccine

Indexed keywords

MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE;

ARTICLE; BRAIN INJURY; DEATH; HEALTH INSURANCE; HUMAN; IMMUNIZATION; LAW SUIT; PRIORITY JOURNAL; VACCINATION;

ACUTE DISEASE; BRAIN DAMAGE, CHRONIC; BRAIN DISEASES; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; REGISTRIES; RUBELLA VACCINE; UNITED STATES; VACCINES, COMBINED;

EID: 0031929384     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.3.383     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention. Measles - United States, 1996, and the interruption of indigenous transmission. MMWR. 1997; 46:242-246
2. Markowitz LE, Katz SL. Measles vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia, PA: WB Saunders Co; 1994:229-276
3. Babbott FL Jr, Gordon JE. Modern measles. Am J Med Sci. 1954;228: 334-361
4. Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis -clinical and immunologic studies. N Engl J Med. 1984;310:137-141
5. Miller DL. Frequency of complications of measles, 1963. Br Med J. 1964;2:75-78
6. Miller HG, Stanton JB, Gibbons JL. Para-infectious encephalomyelitis and related syndromes. Q J Med. 1956;25:427-505
7. Roos RP, Graves MC, Wollman RL, Chilcote RR, Nixon J. Immunologic and virologic studies of measles inclusion body encephalitis in an immunocompromised host: the relationship to subacute sclerosing panencephalitis. Neurology. 1981;31:1263-1270
8. Chen RE, Ramsay DA, deVeber LL, Assiss LJ, Levin SD. Immunosuppressive measles encephalitis. Pediatr Neurol. 1994;10:325-327
9. Institute of Medicine. Adverse Events Associated with Childhood Vaccines -Evidence Bearing on Causality. Washington, DC: National Academy Press; 1994
10. Nadar PR, Warren RJ. Reported neurologic disorders following live measles vaccine. Pediatrics. 1968;41:997-1001
11. Landrigan PJ, Witte JJ. Neurologic disorders following live measles-virus vaccination. JAMA. 1973;223:1459-1462
12. Beghi E, Nicolosi A, Kurland LT, Mulder DW, Hauser WA, Shuster L. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Ann Neurol. 1984;16:283-294
13. Alderslade R, Bellman MH, Rawson NS, Ross EM, Miller DL. The National Childhood Encephalopathy Study: A Report on 1000 Cases of Serious Neurological Disorders in Infants and Young Children From the NCES Research Team. London, England: Her Majesty's Stationery Office; 1981:79-154
14. National Childhood Vaccine Injury Act of 1986, codified as §2111, et seq. of the Public Health Service Act [42 USC 300aa-11 et seq.]
15. National Childhood Vaccine Injury Act of 1986, codified as §2111, et seq. of the Public Health Service Act [42 USC 300aa-11 et seq.]
16. National Vaccine Injury Compensation Program; Revision of the Vaccine Injury Table. Federal Register. February 8, 1995;60:7678-7695
17. Bailar JC, Edemer, F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics. 1964;20:639-643
18. Bellanti JA, Sanga RL, Klutinis B, Brandt B, Artenstein MS. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med. 1969; 280:628-633